Compare General Dynamics Corporation (GD) vs Globus Medical Inc. Class A Common Stock (GMED) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
General Dynamics Corporation vs Globus Medical Inc. Class A Common Stock — how do they compare? General Dynamics Corporation trades at $337.17 (market cap $90.54B), while Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B). The key difference: General Dynamics Corporation is far larger — about 8.8× Globus Medical Inc. Class A Common Stock's market cap, and General Dynamics Corporation pays a 1.9% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold General Dynamics Corporation for 86 Days and Globus Medical Inc. Class A Common Stock for 0 Days on average.
| GD | GMED | |
|---|---|---|
Market Cap | $90.54B | $10.25B |
Volume | 994,070 | 1,059,528 |
Sector | Industrials | Health |
52-Week High | $395.97 | $96.82 |
52-Week Low | $312.53 | $58.33 |
Typical Hold Time | 86 Days | 0 Days |
Enterprise Value | $95.69B | $9.76B |
Dividend Yield | 1.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
General Dynamics (GD) trades at $332.42, down 0.91% on the day, with a bearish technical signal but strong fundamental performance. The company reported revenue of $52.55B in 2025, with net income of $4.21B and a profit margin of 8.18%. Recent earnings beats and a consensus analyst price target of $414.57 suggest upside potential, supported by robust defense spending trends highlighted in recent news (Zacks Investment Research, 2026-10-02).
Outlook remains positive due to consistent earnings growth and strong analyst support, with 57% buy ratings. Key risks include reliance on government contracts and market volatility. The stock's current valuation metrics, including a P/E of 20.27, appear reasonable given its profitability and sector positioning.
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About General Dynamics Corporation
General Dynamics is a defense contractor and business jet manufacturer. The firm's segments include aerospace, combat systems, marine, and technologies. The company's aerospace segment creates Gulfstream business jets. Combat system produces land-based combat vehicles, such as the M1 Abrams tank. The marine subsegment creates nuclear-powered submarines, among other things. The technologies segment contains two main units, an IT business that primarily serves the government market and a mission systems business that focuses on products that provide command, control, computers, intelligence, surveillance, and reconnaissance capabilities to the military.
Read more on GD →About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →
